JWJames Wiginton

James Wiginton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James Wiginton has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changing Frequency of the Use of Intraoperative Equipment Among Neurosurgeons, Neurosurgery Residency Faculty, and Neurosurgery Residents

    by Paras Savla, Tye Patchana, Andrew Ku, James Brazdzionis, James Wiginton, Dan E Miulli

    Neurosurgical procedures have relied on the use of various intraoperative equipment since its advent. These include an operative microscope, ultrasound, and loupes with a headlight. The necessity of these pieces of equipment makes them vital in the training of residents as well. A national survey utilizing a Likert scale to determine how often loupes, microscopes, and ultrasound were used for various neurosurgeries was created. This was then compared to a single program’s responses, and it identified that the practice parameters of residents closely modeled those behaviors portrayed by their attending mentors. It appears that the higher frequency of use by residents when compared to faculty and neurosurgeons nationwide highlights the importance of this equipment in training neurosurgical residents. As such, they should be available to residents from the onset of training to promote the highest quality of learning. Faculty should encourage the use of this equipment by leading by example, and residents, in turn, should use all the available equipment as often as possible to maximize the quality of their training. Modulating the use of learning technologies can be accomplished if it is a nationally accepted practice, discussed in an academic setting with the residents, and modeled by the faculty.


  • Open Access

    Measuring the Electromagnetic Field of Human Subjects Using Induction Sensors and a Shielded Helmet Without the Need for a Shielded Room

    by James Brazdzionis, James Wiginton, Paras Savla, James Hung, Yongming Zhang, Dan E Miulli

    Neurologic activity is mediated by electrochemical signaling pathways that generate an electric charge. These electrical signals generate electromagnetic fields (EMF) that have been found to be measurable through magnetoencephalography and induction sensors. These technologies typically rely on expensive shielding via shielded rooms to remove influence from the external environment. We aimed to investigate the effects of a lightweight shielded helmet constructed of Mu-metal and interlaced copper mesh and Mu-metal EMF “channels” on shielding externally mediated EMF when measuring cortically generated EMF during human activity. Non-contact, non-invasive, proprietary induction sensors were utilized with a combination of a dual-layer Mu-metal and interlaced copper mesh helmet with sensors placed within EMF channels connected to the helmet. Five human volunteers participated in motor activities, verbalization activities, and visual object naming to evaluate the effectiveness of shielding solely via the helmet and EMF channel construct on generated EMF without placement of individuals within a shielded room. Background data without a subject were obtained. Differences in fast Fourier transformed data were noted in the background compared to rest and various activities throughout all trials. There were differences in rest phases and activity phases in each individual identifying active measurement of differences in cortically generated EMF during each activity. It appears that eliminating a Mu-metal shielded room is possible when shielding is isolated to the helmet and EMF channels with induction sensors. The external EMF was appropriately excluded with differences in background data in all trials. During the activity, differences were noted between rest phases and activity phases in all activities noting the discernibility of these induction sensors in measuring cortically generated EMF. Measured activity through motor tapping with changes between 4 and 6 Hz appeared to correlate with previously documented changes during motor activity using these sensors in conjunction with shielded rooms.


  • Open Access

    Measuring the Electromagnetic Field of the Human Brain at a Distance Using a Shielded Electromagnetic Field Channel

    by James Brazdzionis, James Wiginton, Tye Patchana, Paras Savla, James Hung, Yongming Zhang, Dan E Miulli

    The electromagnetic field (EMF) of the human brain generated by the movement of ions in the brain can be measured in a novel manner. The measurement can be completed through the skull, in a non-contact, non-invasive, continuous manner using a lightweight helmet. This investigation was conducted to determine if brain activity from movement and thoughts of movement can be measured at a distance and if that measurement can be readily evaluated at a distance using shielding with a shielded helmet and a shielded EMF channel surrounding a sensor. Non-clinical human subject volunteers donned a lightweight sensor helmet and performed a variety of specific tasks synchronized with an audible tone generated by a metronome. Constructs were created to determine if the human subjects’ brain EMF can be recorded at a distance using sensors surrounded by shielding acting similar to a waveguide in an EMF channel connected to a shielded helmet. The EMF sensors appeared to record brain electromagnetic activity as it is funneled into a shielded channel acting as a waveguide at a considerable distance including distances as far as 63 cm away. Specific brain EMFs from movement, thoughts of movement, and emotional thought can be continuously measured in a non-contact fashion at a distance using an EMF waveguide approach with an EMF channel and shielded helmet.


  • Open Access

    Measuring Electromagnetic Field Activity Generated by Neurons In Vivo by Humans With Thoughts of Repetitive Motor Activities and Emotional Thoughts

    by James Wiginton, James Brazdzionis, Tye Patchana, Paras Savla, James Hung, Yongming Zhang, Dan E Miulli

    In this study, a novel method of electromagnetic field (EMF) measurements of the human brain has been performed to evaluate neuronal activity. This measurement in a non-contact, non-invasive, continuous manner through the human skull and scalp in the standard environment is completed through a lightweight inexpensive helmet. We sought to further delineate whether specific activities of complex thought can be identified using this non-invasive technique. Non-clinical human subject volunteers donned a lightweight helmet with attached sensors and performed activities of motor movement, specific motor imagery, and specific emotional imagery synchronized to an audible tone for consistency. The human subjects’ brain EMF was recorded and analyzed. The novel method of continuously recording real-time human brain EMF was able to determine differing brain activity between individuals performing motor movement, motor imagery, and emotional imagery in a non-contact manner at different distances from the scalp. It may be possible to measure specific human brain activity using EMF in a non-invasive fashion. Emotional imagery, motor imagery, and motor movement generate different EMFs that have different discernible forms compared to baseline activity.


  • Open Access

    Magnesium Levels and Diastolic Blood Pressure (DBP) as a Vasospasm Prediction Metric in Patients With Aneurysmal Subarachnoid Hemorrhage (SAH)

    by Paras Savla, Maxwell A Marino, Dario A Marotta, James Brazdzionis, Saman Farr, Stacey Podkovik, James Wiginton, Emilio C. Tayag, Vladimir Cortez, Dan E Miulli

    Vasospasm is a significant cause of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (SAH). The purpose of this study is to evaluate a possible link between vasospasm in patients with aneurysmal SAH and magnesium and blood pressure levels. Subjects were selected based on chart review of patients presenting to a comprehensive stroke center in Southern California with aneurysmal SAH. 27 were included based on the following criteria: patients greater than 18 years of age, aneurysmal SAH, clinically symptomatic vasospasms and at least one diagnostic confirmation - either from a transcranial doppler (TCD) or digital subtraction angiogram (DSA). The following exclusion criteria also applied: 1) incomplete documentation in the medical record; 2) patients <18 years of age; and 3) patients without TCD measurements. In an overall analysis of all patients with or without vasospasm, it was found that the presence of vasospasm was significantly correlated with diastolic blood pressures (DBPs) on day of vasospasm with an r value of 0.418 and p<0.001. Average daily DBPs throughout hospital stay were also correlated with vasospasm with an r-value of 0.455 and p<0.001. Changes in magnesium overall were also significantly related to left Lindegaard ratios with an r value of -0.201 and p value of 0.032. Lindegaard ratios were significantly correlated with age with r values of 0.510, p<0.001, and r=-0.482, p<0.001 for left and right, respectively. A change in magnesium was inversely correlated to the left Lindegaard ratio with an n of 31 and p value of 0.014 (r= -0.439) in patients with vasospasm. We also found a lower incidence of vasospasm in patients older than 65. Monitoring magnesium and increases in DBP might be effective as a prophylactic adjunct method in patients with SAH in an effort to predict clinical vasospasm.

  • Open Access

    Evaluating the Intrinsic Electromagnetic Field Generated by Neurons From Repetitive Motor Activities in Humans With a Non-contact Non-invasive Electromagnetic Helmet

    by James Brazdzionis, James Wiginton, Tye Patchana, Paras Savla, James Hung, Yongming Zhang, Dan E Miulli

    The actions of neurons are dependent on electrochemical signal pathways mediated by neurotransmitters and create measurable electrical charges. These charges have been found to be measurable through neuroimaging technologies and now through a novel non-contact non-invasive sensor without supercooling. Identifying whether this technology can be appropriately interpreted with synchronized motor well-defined activities in vivo may allow for further clinical applications. A non-contact, non-invasive helmet constructed and modified using shielding technology with proprietary magnetic field sensors was utilized to measure the brain’s electromagnetic field (EMF). Human volunteers donned helmets and were asked to perform repetitive tapping exercises in order to identify waves consistent with tapping from the left and right hemispheres. A gyroscope was utilized to ensure that measured waves were not from micro-movement but were from neuronal firing. Multiple individuals were tested to evaluate the reproducibility of tapping and commonalities between individuals Right and left-sided tapping generated discernible wave changes from baseline measurements obtained by the helmet without a subject as well as differed from when the subject was at rest. Wave patterns varied from person to person but were overall similar in each subject individually. Shielding was necessary to identify signals but EMF was identified when shielding was transitioned from around the helmet to within the helmet design. It is possible to measure in-vivo electromagnetic fields generated by the human brain generated by stereotyped tasks in a non-contact non-invasive manner. These waves were reliably obtained within each individual with some variability in morphology from subject to subject however were similar in each subject. Signals varied based on activity and stereotyped motor activities were identified. A helmet using shielding technology within the helmet itself was able to effectively identify EMF signals. Future analysis may focus on translating these waves into functional mapping for clinical applications.


  • Open Access

    Novel Method of Electromagnetic Field Measurements of the Human Brain

    by James Wiginton, James Brazdzionis, Tye Patchana, James Hung, Yongming Zhang, Dan E Miulli

    Advancements in neuroimaging have changed the field of medicine. Computed tomography (CT) and magnetic resonance imaging (MRI) typically produce a static image of the brain, while continuous electroencephalogram (EEG) data is limited to the cortical surface. The brain’s chemical reactions produce an electric circuit that generates a magnetic field. We seek to test the ability of a non-contact sensor to measure the human brain’s electromagnetic field (EMF). A lightweight, inexpensive construct was designed to hold EMF sensors to non-invasively measure the human brain’s dynamic EMF. Measurements were conducted on non-clinical human volunteers. Background data without the human subjects was obtained, followed by introducing human subjects. Motionless human subject data was obtained, followed by a subject performing a task. Finally, a subject received auditory stimulation, and data was obtained. Our non-contact sensor was able to detect a difference between background activity without a human subject and the electromagnetic field of a human brain within the scalp and skull. Detectable differences in magnetic field potential were also obtained when the subject performed a task and received auditory stimulation. It is possible to continuously measure living human brain dynamic electromagnetic fields throughout the entire brain in a non-contact, non-invasive, continuous manner through the human scalp and skull in the standard environment. The signals are unique to the individual human and can be differentiated from background activity.


  • Open Access

    Using the Decrease in Trauma Admissions During the COVID-19 Pandemic to Evaluate Compliance With Stay-at-Home and Social Distancing Guidelines

    by Paras Savla, James Wiginton, Taha M. Taka, Tye Patchana, Ronit Farahmandian, Saman Farr, James A Berry, Mark Krel, Kevin Ray, Sarah Petrova, et al.

    The coronavirus disease 2019 (COVID-19) virus was declared a pandemic on March 10, 2020 by the World Health Organization (WHO) and has massively burdened healthcare systems with cases exponentially rising throughout the United States and the rest of the world. Since implementing precautions to reduce the spread of this disease, emergency departments have seen a decrease in the number of traumas. By evaluating the differences in the number of trauma admissions in different subgroups of patients, we can assess where to target messaging to increase compliance with these precautions. In this study, we aim to analyze the effect of the COVID-19 pandemic on trauma admissions. This was a retrospective review of the trauma database at our institution, a level 2 trauma center in Southern California, to assess the impact of COVID-19 on the number of traumas. The inclusion criteria were patients activated as traumas, regardless of age. Patients were excluded from the study if they did not have complete information in the trauma database. Data were stratified by date into two groups: (a) COVID period (January to April 2020) and (b) pre-COVID period (January to April 2019). The primary endpoint of this study was to determine whether there was a significant change in the number of patients presenting as trauma during the COVID-19 pandemic. This difference was analyzed and divided into subgroups based on age and trauma type. In our review, an average of 279 patients per month presented as trauma from January to April in 2019, and an average of 222 patients per month presented as trauma from January to April 2020 (p = 0.049). We found a significant decrease in the number of patients presenting with the chief complaint of fall and vehicular accident, but a nonsignificant difference in patients presenting as assaults or pedestrian accidents. There was also a significant decrease in the number of traumas in the 18-39 and 65+ age groups and a nonsignificant decrease in the 40-64 age group. It was also noted that the number of trauma admissions in May 2020 increased to 253 compared to 269 in 2019. This increase was most notable in the 18-39 and 40-64 age groups. As seen in the data, the most notable year-over-year difference was seen in March and April. In California specifically, a stay-at-home order was set in place in March, which was in conjunction with the WHO’s declaration of a pandemic. An interesting finding was the significant decrease in patients with traumas in the age groups of 18-39 and 65+ from 2019 to 2020. There was a smaller, nonsignificant decrease in patients aged 40-64. This would be a good group to target with future messaging to increase compliance with health advisories. There was also a notable increase in the number of traumas in May 2020, signaling an end to the cooperation of the majority of people, also indicating that further measures needed to be enacted in all groups. COVID-19 has disrupted social structures worldwide. As the pandemic continued, even the observers of stay-at-home and social distancing measures, the 18-39 age group, became fatigued with the guidelines and ventured out into the warming weather and summer activities. This difference in trauma admission due to COVID-19 between subsequent years can highlight the behavioral changes in our patient population and can be further extrapolated to target additional messaging to help reduce the spread of COVID-19.


  • Retraction
    Open Access

    Racial Disparity Amongst Stroke Patients During the Coronavirus Disease 2019 Pandemic

    by Hammad Ghanchi, Tye Patchana, James Wiginton, Jonathan D. Browne, Ai Ohno, Ronit Farahmandian, Jason Duong, Vladimir Cortez, Dan E Miulli

    This article has been retracted as it includes data published without permission from the Get With the Guidelines database, which is property of American Heart Association (AHA). Although the authors' hospital had access to this database and they did receive IRB approval, the terms of use between the hospital and AHA do not allow publication of the data in a public sphere. The authors were hoping to receive retrospective approval from the AHA but have not been successful in getting this permission thus far. As a result this article has been retracted at the request of the AHA and with full agreement by the authors.


  • Open Access

    Inflammatory Markers in Severity of Intracerebral Hemorrhage II: A Follow Up Study

    by Jacob E Bernstein, Jonathan D. Browne, Paras Savla, James Wiginton, Tye Patchana, Dan E Miulli, Margaret Rose Wacker, Jason Duong

    Spontaneous intracerebral hemorrhage (ICH) results in significant morbidity and mortality. The pathogenesis of brain injury after ICH is thought to be due to mechanical damage followed by ischemic, cytotoxic, and inflammatory changes in the underlying and surrounding tissue. Various inflammatory and non-inflammatory biomarkers have been studied as predictors and potential therapeutic targets for intracerebral hemorrhage. Our prior study showed an association with low vascular endothelial growth factor (VEGF) levels and increased mortality. This current study looks to expand on our prior results and will look at the relationship between tumor necrosis factor alpha (TNFα), C-reactive protein (CRP), VEGF, Homocysteine (Hcy), and CRP to albumin ratio (CAR) in predicting outcomes and severity in spontaneous intracerebral hemorrhage. We conducted a retrospective chart review of patients with spontaneous intracerebral hemorrhage with TNFα, CRP, VEGF, Hcy levels drawn on admission. Albumin and CRP levels on admission were used to calculate CAR. Ninety-nine patients were included in the study. Primary outcomes included death, early neurologic decline (END), and hemorrhage size. Secondary outcomes included late neurologic decline (LND), Glasgow Coma Scale (GCS) on admission, GCS on discharge, ICH score, change in hemorrhage size, need for surgical intervention, and length of ICU stay. A total of 99 patients were included in this study, with 42% requiring surgical intervention and an overall mortality of 16%. Basal ganglia hemorrhage was seen in 41% of patients. Hcy and CAR were significantly correlated with ICH size in basal ganglia patients (r-=0.36, p=0.03; r=0.43, p=0.03, respectively). CAR was significantly correlated with ICH score (r=0.33, p=0.007874). Admission VEGF levels less than 45 pg/ml had 8.4-fold increase in mortality (odds ratio [OR] 8.4545, p=0.0488). Patients with TNFα levels greater than 1.40 pg/ml had a 4.1-fold increase in mortality (OR 4.1, p=0.04) Our study demonstrated that low levels (<45 pg/ml) of VEGF were associated with an 8.4-fold increase in mortality, supporting the neuroprotective effect of this protein. Elevated Hcy and CAR levels were associated with an increase in hemorrhage size in patients with basal ganglia hemorrhages. TNFα levels greater than 1.40 pg/ml were associated with a 4.1-fold increase in mortality, and this together with CAR being correlated with increased hemorrhage size and ICH score further demonstrate the inflammatory consequences after intracerebral hemorrhage. Future studies directed at lowering CRP, TNFα, and Hcy and/or increasing VEGF in intracerebral hemorrhage patients are needed and may be beneficial.